AstraZeneca Pharma India Ltd has received approval from the Central Drugs Standard Control Organisation (CDSCO) to import and distribute the cancer treatment drug Olaparib, branded as Lynparza, in India. The approval allows the company to import the drug in film-coated tablet form in dosages of 100 mg and 150 mg for sale and distribution in the country.
Open FlipReported Standalone quarterly numbers for PG Foils are: Net Sales at Rs 100.27 crore in September 2024 up 66.14% from Rs. 60.36 crore in September 2023. Quarterly Net Profit at Rs. 6.86 crore in September 2024 up 1495.93% from Rs. 0.43 crore in September 2023. EBITDA stands at Rs. 10.65 crore in September 2024 up 201.7% from Rs. 3.53 crore in September 2023.
Open FlipReported Standalone quarterly numbers for Nirav Commercial are: Net Sales at Rs 2.48 crore in September 2024 down 14.78% from Rs. 2.91 crore in September 2023. Quarterly Net Loss at Rs. 0.01 crore in September 2024 down 102.08% from Rs. 0.48 crore in September 2023. EBITDA stands at Rs. 0.07 crore in September 2024 down 87.04% from Rs. 0.54 crore in September 2023.
Open Flip